Type 2 Diabetes (T2D) Susceptibility Loci and Beta Cell Defects in Islets (ISLs) from Non-Diabetic (ND) and T2D Subjects

被引：0
|
作者：
Del Guerra, Silvia
Groves, Christopher
D'Aleo, Valentina
Lupi, Roberto
Maccarthy, Mark
Marchetti, Piero
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1405-P
引用
收藏
页码：A387 / A387
页数：1
相关论文
共 50 条
  • [31] Mechanisms of the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes (T2D)
    Muscelli, Elza
    Casolaro, Arturo
    Gastaldelli, Amalia
    Mari, Andrea
    Seghieri, Giuseppe
    Chen, Yu
    Alba, Maria
    Holst, Jens
    Ferrannini, Ele
    DIABETES, 2011, 60 : A267 - A267
  • [32] Dapagliflozin (DAPA) in Patients with Type 2 Diabetes (T2D) and Mixed Dyslipidemia
    Bays, Harold E.
    Sartipy, Peter
    Xu, John
    Langkilde, Anna Maria
    Sjostrom, C. David
    DIABETES, 2016, 65 : A306 - A306
  • [33] Renal Impairment and Antidiabetic Medication Use in Type 2 Diabetes (T2D)
    Koro, Carol E.
    Stender, Monika
    Sowell, Margaret
    Bourgeois, Nancy
    Spain, C. Victor
    DIABETES, 2014, 63 : A636 - A636
  • [34] Genomic Data and Disease Forecasting: Application to Type 2 Diabetes (T2D)
    Sirovich, Lawrence
    PLOS ONE, 2014, 9 (01):
  • [35] PowerHouse: A Lifestyle Intervention for Youth at Risk for Type 2 Diabetes (T2D)
    El Mikati, Hala K.
    Pike, Julie
    Haberlin-Pittz, Katie
    Yazel-Smith, Lisa
    Mckinney, Brett M.
    Hannon, Tamara S.
    DIABETES, 2019, 68
  • [36] Initial Presentation of Type 2 Diabetes (T2D) in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium (PDC) T2D Registry
    Bacha, Fida
    Tamborlane, William V.
    Klingensmith, Georgeanna J.
    Change, Peiyao
    Gal, Robin L.
    Kollman, Craig
    Beck, Roy W.
    Manseau, Katherine
    Wood, Jamie R.
    DIABETES, 2016, 65 : A67 - A67
  • [37] β-Cell Stimulation by Saxagliptin in Patients with T2D
    Henry, Robert
    Smith, Steven
    Schwartz, Sherwyn
    List, James
    Duan, Raina Yuyan
    Chen, Roland
    DIABETES, 2009, 58 : A119 - A119
  • [38] Ertugliflozin in Older Patients with Type 2 Diabetes (T2D): An Analysis from VERTIS CV
    Pratley, Richard E.
    Dagogo-Jack, Samuel
    Charbonnel, Bernard
    Cherney, David
    Cosentino, Francesco
    Mcguire, Darren K.
    Essex, Margaret N.
    Jones, Philip L. S.
    Liu, Jie
    Adamsons, Ingrid A.
    Lawrence, David
    Shih, Weichung J.
    Cannon, Christopher P.
    DIABETES, 2021, 70
  • [39] Exome Chip Analysis of 9,990 Type 2 Diabetes (T2D) Cases and 51,945 Controls Identifies Novel Rare and Low Frequency Coding Variation in Known T2D Susceptibility Loci
    Chu, Audrey Y.
    Hildago, Bertha
    Wang, Shuai
    Chen, Yuning
    Willems, Sara M.
    Scott, Robert A.
    Dauriz, Marco
    An, Ping
    Baldridge, Abigail
    Huffman, Jennifer E.
    Guo, Xiuqing
    Jensen, Richard A.
    Lange, Leslie
    Li, Man
    Liao, Jiemin
    Lu, Yingchang
    Meidtner, Karina
    Nalls, Michael A.
    Smith, Albert
    Southam, Lorraine
    Strawbridge, Rona J.
    Hivert, Marie-France
    Rotter, Jerome I.
    Siscovick, David S.
    Dupuis, Josee
    Meigs, James B.
    Wessel, Jennifer
    Goodarzi, Mark O.
    DIABETES, 2014, 63 : A74 - A74
  • [40] MicroRNAs 9 and 370 Association with Biochemical Markers in T2D and CAD Complication of T2D
    Motawae, Tarek M.
    Ismail, Manal F.
    Shabayek, Marwa I.
    Seleem, Mae M.
    PLOS ONE, 2015, 10 (05):
12345